You are currently offline. Some features of the site may not work correctly.
PI3K Alpha/Beta Inhibitor BAY1082439
Known as: BAY1082439
An orally bioavailable inhibitor of the class I phosphoinositide 3-kinase (PI3K) alpha and beta isoforms with potential antineoplastic activity. PI3K… Expand
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.